Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01255995
Other study ID # 2PR2240936
Secondary ID
Status Active, not recruiting
Phase N/A
First received December 2, 2010
Last updated November 15, 2012
Start date December 2010
Est. completion date May 2022

Study information

Verified date November 2012
Source Aurolab
Contact n/a
Is FDA regulated No
Health authority India: Institutional Review Board
Study type Observational

Clinical Trial Summary

- The purpose of this study is to determine the natural course of IOL in PXF,

- To demonstrate use of a clinical grading system for PXF,

- To strategize a way to prevent IOL dislocation, subluxation post operatively,

- To demonstrate intraoperative and long-term post-operative complications associated with phaco and PXF

- To suggest evidence-based ways to minimize these complications, by using capsular tension rings (CTR), specific IOL material or size


Description:

Pseudo exfoliation syndrome (PXF) is a generalized degenerative microfibrillopathy that primarily is manifested with deposits of exfoliative material present on the anterior capsule of the crystalline lens, zonules, papillary margin of the iris, corneal endothelium, ciliary body and the trabecular meshwork. The build of this exfoliative material causes microscopic changes of the zonules and their attachments, causing a weakening of the zonules. These clinical findings have implications not only for cataract surgery, as association of lens opacities with exfoliation syndrome is well documented but also for glaucoma, with exfoliative glaucoma being the most common cause for secondary open angle glaucoma in the world.In patients with exfoliation syndrome, small pupil and phacodonesis, comparison between extra capsular cataract extraction and small incision cataract surgery revealed better best corrected visual acuity and fewer intra and post operative complications with the smaller incision for phacoemulsification. The capsular tension rings (CTR) implanted prior to phacoemulsification reduced intraoperative zonular dialysis, increased the rate of capsular IOL fixation, and improved uncorrected visual acuity. Either the degree of lens change the stage of PXF, or the type of IOL might influence long term outcome in PXF associated with cataract surgery:The postoperative course of those with either more advanced cataract or with more advanced PXF may be different than those who have surgery with less cataract our and/or degree of PXF. The stage of PXF alone at the time of cataract surgery may influence outcome. Once PXF identified, surgery performed at an earlier stage of cataract with a softer lens in XFS results in fewer long term problems following phacoemulsification. A standardized way of clinically measuring/monitoring XFS is helpful during large clinical studies Specific intraocular lens design should be considered when scheduling phacoemulsification in patients with PXF.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1500
Est. completion date May 2022
Est. primary completion date December 2021
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 40-75

- PXF with or without secondary open-angle glaucoma who present with cataract and willing to undergo phacoemulsification with IOL

- Nuclear sclerosis with LOCS III grade and above

- Pupil size more than 4mm on dilatation

- Endothelial cell count >1,500

- No visible phacodonesis

Exclusion Criteria:

- Uncontrolled IOP/glaucoma

- History of narrow angles, chronic narrow angle glaucoma

- Any pre-existing clinical zonular dialysis or phacodonesis

- Pseudo uveitis

- One eyed patients

- Cardiac pathology

- Uncontrolled diabetes, hypertension & severe asthma

- Obviously debilitated patients

- Traumatic cataract

- Complicated cataract

- Congenital cataract

- Drug induced cataract

- Shallow anterior Chamber

- Amblyopia

- Dense posterior polar cataract

- Corneal pathology

- Retinal pathology

- RAPD

- Severe visual field defect (MD->12.0dB)

- Diabetic retinopathy

- Combined Surgery

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Device:
Capsular Tension Ring
Capsular Tension Ring

Locations

Country Name City State
India Aravind Eye Hospital Coimbatore Tamil Nadu
India Aravind Eye Hospital Madurai Tamil Nadu
India Aravind Eye Hospital Pondicherry Tamil Nadu
India Aravind Eye Hospital Tirunelveli Tamil Nadu

Sponsors (1)

Lead Sponsor Collaborator
Aurolab

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary IOL Centration / IOL Stability 10th Year No
Secondary Visual Acuity 10th Year No
Secondary Anterior capsular fibrosis/phimosis 10th Year No
Secondary New onset of phacodonesis 10th Year Yes
Secondary Development or worsening of glaucoma 10th Year Yes
See also
  Status Clinical Trial Phase
Recruiting NCT03310788 - Monitoring of the IOP After SLT Using iCare Home
Recruiting NCT06154330 - Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas
Terminated NCT03445806 - IOP Monitoring After Trabeculectomy Using iCare Home
Completed NCT04911387 - iCare® Home vs Goldmann Applanation Tonometry